Emcure Pharmaceuticals Limited (NSE:EMCURE)
India
· Delayed Price · Currency is INR 1,521.10
+105.30 (7.44%)
At close: Mar 9, 2026
Emcure Pharmaceuticals Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Revenue | 88,501 | 78,960 | 66,583 | 59,858 | 58,554 | 50,335 | Upgrade
|
| Revenue Growth (YoY) | 17.20% | 18.59% | 11.23% | 2.23% | 16.33% | -0.30% | Upgrade
|
| Cost of Revenue | 36,220 | 32,225 | 25,357 | 23,185 | 22,864 | 19,269 | Upgrade
|
| Gross Profit | 52,281 | 46,735 | 41,225 | 36,673 | 35,690 | 31,065 | Upgrade
|
| Selling, General & Admin | 18,189 | 17,264 | 15,577 | 13,069 | 11,805 | 10,272 | Upgrade
|
| Other Operating Expenses | 17,162 | 14,782 | 13,351 | 11,597 | 10,562 | 8,606 | Upgrade
|
| Operating Expenses | 39,406 | 35,887 | 32,052 | 27,459 | 24,835 | 21,402 | Upgrade
|
| Operating Income | 12,874 | 10,847 | 9,173 | 9,214 | 10,855 | 9,663 | Upgrade
|
| Interest Expense | -906.83 | -1,302 | -2,032 | -1,849 | -1,470 | -1,140 | Upgrade
|
| Interest & Investment Income | 90.44 | 90.44 | 207.59 | 118.34 | 101.97 | 69.87 | Upgrade
|
| Currency Exchange Gain (Loss) | 1,326 | 437.59 | 203.77 | 190.15 | 367.78 | 30.33 | Upgrade
|
| Other Non Operating Income (Expenses) | -855.72 | -314.36 | -205.93 | -137.55 | -124.92 | -66.8 | Upgrade
|
| EBT Excluding Unusual Items | 12,528 | 9,759 | 7,346 | 7,536 | 9,730 | 8,557 | Upgrade
|
| Gain (Loss) on Sale of Investments | 58.04 | 58.04 | 25.32 | 1.21 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | -3.33 | -4.08 | 4.29 | Upgrade
|
| Other Unusual Items | -520.28 | -103.78 | -99.31 | -61.46 | - | -153.82 | Upgrade
|
| Pretax Income | 12,066 | 9,713 | 7,272 | 7,472 | 9,725 | 8,407 | Upgrade
|
| Income Tax Expense | 3,118 | 2,639 | 1,997 | 1,854 | 2,700 | 2,334 | Upgrade
|
| Earnings From Continuing Operations | 8,948 | 7,075 | 5,276 | 5,618 | 7,026 | 6,073 | Upgrade
|
| Earnings From Discontinued Operations | - | - | - | - | - | -1,887 | Upgrade
|
| Net Income to Company | 8,948 | 7,075 | 5,276 | 5,618 | 7,026 | 4,186 | Upgrade
|
| Minority Interest in Earnings | -248.55 | -261.35 | -293.92 | -298.26 | -403.56 | -264.47 | Upgrade
|
| Net Income | 8,699 | 6,813 | 4,982 | 5,320 | 6,622 | 3,921 | Upgrade
|
| Net Income to Common | 8,699 | 6,813 | 4,982 | 5,320 | 6,622 | 3,921 | Upgrade
|
| Net Income Growth | 43.19% | 36.76% | -6.36% | -19.66% | 68.86% | 369.04% | Upgrade
|
| Shares Outstanding (Basic) | 190 | 187 | 181 | 181 | 181 | 181 | Upgrade
|
| Shares Outstanding (Diluted) | 190 | 187 | 181 | 181 | 181 | 181 | Upgrade
|
| Shares Change (YoY) | 2.49% | 3.41% | 0.01% | - | - | - | Upgrade
|
| EPS (Basic) | 45.90 | 36.43 | 27.54 | 29.42 | 36.62 | 21.68 | Upgrade
|
| EPS (Diluted) | 45.90 | 36.43 | 27.54 | 29.42 | 36.62 | 21.68 | Upgrade
|
| EPS Growth | 39.72% | 32.27% | -6.38% | -19.66% | 68.90% | 369.23% | Upgrade
|
| Free Cash Flow | - | 6,299 | 8,215 | 3,563 | 3,900 | 5,790 | Upgrade
|
| Free Cash Flow Per Share | - | 33.68 | 45.42 | 19.70 | 21.57 | 32.02 | Upgrade
|
| Dividend Per Share | - | 3.000 | - | 2.000 | 3.000 | 1.000 | Upgrade
|
| Dividend Growth | - | - | - | -33.33% | 200.00% | -60.00% | Upgrade
|
| Gross Margin | 59.07% | 59.19% | 61.92% | 61.27% | 60.95% | 61.72% | Upgrade
|
| Operating Margin | 14.55% | 13.74% | 13.78% | 15.39% | 18.54% | 19.20% | Upgrade
|
| Profit Margin | 9.83% | 8.63% | 7.48% | 8.89% | 11.31% | 7.79% | Upgrade
|
| Free Cash Flow Margin | - | 7.98% | 12.34% | 5.95% | 6.66% | 11.50% | Upgrade
|
| EBITDA | 16,630 | 14,121 | 11,805 | 11,446 | 12,911 | 12,419 | Upgrade
|
| EBITDA Margin | 18.79% | 17.88% | 17.73% | 19.12% | 22.05% | 24.67% | Upgrade
|
| D&A For EBITDA | 3,756 | 3,274 | 2,632 | 2,232 | 2,057 | 2,756 | Upgrade
|
| EBIT | 12,874 | 10,847 | 9,173 | 9,214 | 10,855 | 9,663 | Upgrade
|
| EBIT Margin | 14.55% | 13.74% | 13.78% | 15.39% | 18.54% | 19.20% | Upgrade
|
| Effective Tax Rate | 25.84% | 27.17% | 27.45% | 24.81% | 27.76% | 27.77% | Upgrade
|
| Revenue as Reported | 88,632 | 79,633 | 67,021 | 60,317 | 59,189 | 50,674 | Upgrade
|
| Advertising Expenses | - | 2,734 | 2,585 | 1,828 | 1,633 | 1,220 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.